Rise in the prevalence of chronic diseases is expected to drive market expansion shortly at a CAGR of 4.00% during the forecast period 2024 to 2032.

Market Research Future (MRFR) has published a cooked research report on the “Medical Imaging Phantoms Market” that contains information from 2019 to 2032. The Medical Imaging Phantoms Market is estimated to register a CAGR of 4.00% during the forecast period of 2024 to 2032.

MRFR recognizes the following companies as the key players in the global Medical Imaging Phantoms Market— PTW Freiburg GmbH, Gold Standard Phantoms, Kyoto Kagaku Co., Ltd., Pure Imaging Phantoms, Dielectric Corporation, Modus Medical Devices, Carville Limited, Mirion Technologies, Inc., Leeds Test Objects.

Medical Imaging Phantoms Market Highlights

The global Medical Imaging Phantoms Market is accounted to register a CAGR of 4.00% during the forecast period and is estimated to reach USD 0.29 billion by 2032.

The significant growth of the global medical imaging phantoms market is propelled by the escalating disease burden associated with lifestyle-related conditions such as cardiac failure, chronic kidney disease, and chronic obstructive pulmonary disease (COPD). Additionally, there is an increasing need for precise calibration methods to enhance the efficacy of diagnostic imaging procedures.

Segment Analysis

The global Medical Imaging Phantoms Market has been segmented based on Device Type and End User.

Based on the Device Type, the market is segmented into X-ray/Fluoroscopy Phantoms, Ultrasound Phantoms, CT Phantoms, MRI Phantoms, Nuclear Imaging Phantoms, and Others. The nuclear imaging phantoms segment was attributed to holding the largest market share in 2023. The nuclear imaging phantoms sector is anticipated to expand because the nuclear imaging phantoms are constructed with extremely specific anatomical structures to enhance their applications in biomedical studies as well as bioengineering research. As a result, these anatomically realistic modifications in phantoms will promote the creation of a superior computational model for the nuclear imaging field, which, in return, will drive market growth during the given period.

Based on the End User, the Medical Imaging Phantoms Market has been segmented into Hospitals, Academic & Research Institutes, Diagnostic & Reference Laboratories, and Medical Device Companies. The hospitals segment was expected to hold the largest market share in 2023. Hospitals are the main consumers of medical imaging devices and phantoms because they conduct much diagnostics imaging daily. The number of hospitals rising thereon contributes to the market being at an advantage. Also, the development of effective reimbursement processes in specific hospitals of many of the nations worldwide, which eases the financial burden for the patients, is a major factor that promotes the hospital segment expansion.

Explore In-depth Market Details [Table of Content, List of Figures, List of Tables] of Medical Imaging Phantoms Market Research Report

Regional Analysis

The global Medical Imaging Phantoms Market, based on region, has been divided into North America, Europe, Asia-Pacific, and Rest of the World. North America consists of the US and Canada. The Europe Medical Imaging Phantoms Market comprises of Germany, France, the UK, Italy, Spain, and the rest of Europe. The Medical Imaging Phantoms Market in Asia-Pacific has been segmented into China, India, Japan, Australia, South Korea, and the rest of Asia-Pacific. The Rest of the World Medical Imaging Phantoms Market comprises the Middle East, Africa, and Latin America.

The largest market share for the Medical Imaging Phantoms Market was maintained by the North American regional sector. The funding increase in the region will likely result in higher medical imaging use and expand the market. For instance, in 2021, to bring to Quebecker's healthcare and social services infrastructure, particularly hospitals and other care facilities, the government of Canada and the province of Quebec joined working in establishing 209 infrastructure projects partly by the share of $188.3 million each from the Federal side and the province. Funding gave hospitals in-depth access in terms of complicated medical technology. Therefore, during the projection phase, the development of new hospitals will surely raise the popularity of medical imaging; it is anticipated that such popularity will increase the demand for a medical imaging phantom across the region.

Moreover, the Europe market has been persistently growing over the forecast period. A majority of European countries are developed in healthcare, having great involvement in medical technologies and infrastructure investment. Along with the increasing cost of healthcare, healthcare facilities are becoming more and more tempted to provide their patients with the latest diagnostic imaging and medical equipment and quality checks like medical imaging phantoms. In 2022, all member states' social protection sickness and health spending, measured as the percentage of GDP, amounted to 8.1%, of which 0.4 pp or 0.1 percentage points less than in the previous year, which is 8.5%. Among the 24 EU countries for which 2022 estimates are available, social protection sickness and healthcare expenditure was highest in France (10.0% of GDP), Germany (9.7%), Slovenia (8.6%), Austria (8.5%), and Belgium (7.8%), while it was lowest in Bulgaria (4.2%), Ireland (4.6%), Hungary, Lithuania (both 4.7%) and Estonia (4.8%)

The Medical Imaging Phantoms Market in the Asia Pacific region has already experienced vast growth driven by such factors as increased healthcare expenses, increased population, urbanization, people getting richer, and expanding awareness about their health issues. As for China, healthcare spending has tremendously been on the rise, with the statistic figures of RMB 500 billion yuan in 2000 now increasing to more than RMB 6.5 trillion by the year 2019. Furthermore, the overall amount of healthcare expenses in China could increase to more than eight and a half trillion RMB in the year 2022. In FY 19, NHA (National Health Account) shows that there has been an increment in GHE (gross health expenditure) from 1.2% to 1.3% in the total GDP, whereas FY14 and FY19, respectively; this just indicates a 0.1 % growth in GHE. Along with the abovementioned, a higher percentage of GHE is found in THE as of FY19, which reached 40.6 percent, in contrast to FY14, which stood at 28.6 percent.

Furthermore, the rest of the world's Medical Imaging Phantoms Market is divided into the Middle East, Africa, and Latin America. The prevalence of chronic diseases such as cancer, cardiovascular diseases, and orthopedic ailments is on the rise in these regions. In 2022, an estimated total of 1.5 million new cancer cases and 700,000 deaths occurred annually in Latin America and the Caribbean region, with corresponding incidence and mortality rates of 186.5 and 86.6 per 100,000. The most common cancers in 2020 were prostate (15%), breast (14%), colorectal (9%), lung (7%) and stomach (5%). Medical imaging plays a crucial role in the diagnosis, treatment planning, and monitoring of these conditions, leading to a higher demand for imaging phantoms for accurate calibration and testing of imaging equipment.

Key Findings of the Study

• The global Medical Imaging Phantoms Market is expected to reach USD 0.29 billion by 2032, at a CAGR of 4.00% during the forecast period.


• The Asia-Pacific region accounted for the fastest-growing global market because of the increasing focus on the development of healthcare infrastructure and the rising prevalence of various chronic disorders.


• Based on device type, the nuclear imaging phantoms segment was attributed to holding the largest market in 2023, with an approximate market share of 55–60%


• PTW Freiburg GmbH, Gold Standard Phantoms, Kyoto Kagaku Co., Ltd., Pure Imaging Phantoms, Dielectric Corporation, Modus Medical Devices, Carville Limited, Mirion Technologies, Inc., Leeds Test Objects are the key market players.